GRAIL, Inc.
Clinical trials sponsored by GRAIL, Inc., explained in plain language.
GRAIL, Inc.
GRAL
NASDAQ
A healthcare company developing early cancer detection tests, subsidiary of Illumina.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.